Table 2– Baseline characteristics and measurements of subjects in the ARTEMIS-IPF study and Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (GAP) study cohort
Baseline characteristics and measurementsARTEMIS-IPFGAP cohort
No serumSerum
Age years65.9±7.366.2±7.066.7±8.9
Males303 (72)52 (75)73 (70)
FVC % predicted69.0±13.569.8±12.166.1±17.7#
DLCO % predicted43.4±14.142.1±11.147.8±18.0#
6MWD m416.2±120.1398.6±115.8NA
PAP mmHg20.4±7.120.4±5.9NA
CPI score52.2±10.852.5±8.951.0±13.0
SGRQ score39.4±19.538.0±18.4NA
TDI score7.3±2.47.5±2.4NA
Follow-up days median±sd237±143245±177455±340
Deaths23 (5)9 (13)43 (41)
  • Data are presented as n, mean±sd or n (%), unless otherwise stated. FVC: forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; 6MWD: 6-min walking distance; PAP: pulmonary arterial pressure; CPI: composite physiological index; SGRQ: St George’s Respiratory Questionnaire; TDI: transition dyspnoea index; NA: not applicable. #: only 70 (67%) subjects had baseline pulmonary function data available; : censored at 24 months after enrolment, lung transplant (n=17) was treated as a mortality event.